Valley National Advisers’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.79M | Sell |
10,758
-23
| -0.2% | -$8.2K | 0.49% | 39 |
|
|
2025
Q4 | $3.53M | Sell |
10,781
-75
| -0.7% | -$23.8K | 0.49% | 34 |
|
|
2025
Q3 | $3.06M | Sell |
10,856
-18
| -0.2% | -$5.22K | 0.47% | 43 |
|
|
2025
Q2 | $3.04M | Sell |
10,874
-343
| -3% | -$97.2K | 0.5% | 41 |
|
|
2025
Q1 | $3.49M | Sell |
11,217
-943
| -8% | -$278K | 0.63% | 31 |
|
|
2024
Q4 | $3.17M | Sell |
12,160
-1,374
| -10% | -$408K | 0.57% | 35 |
|
|
2024
Q3 | $4.36M | Sell |
13,534
-10,100
| -43% | -$3.3M | 0.79% | 22 |
|
|
2024
Q2 | $7.38M | Sell |
23,634
-932
| -4% | -$274K | 1.1% | 19 |
|
|
2024
Q1 | $6.98M | Sell |
24,566
-578
| -2% | -$169K | 1.06% | 23 |
|
|
2023
Q4 | $7.24M | Sell |
25,144
-1,188
| -5% | -$324K | 1.15% | 20 |
|
|
2023
Q3 | $7.08M | Sell |
26,332
-333
| -1% | -$83.1K | 1.24% | 20 |
|
|
2023
Q2 | $5.92M | Sell |
26,665
-22
| -0.1% | -$5.11K | 1% | 22 |
|
|
2023
Q1 | $6.52M | Sell |
26,687
-213
| -0.8% | -$52.3K | 1.15% | 21 |
|
|
2022
Q4 | $7.34M | Sell |
26,900
-726
| -3% | -$195K | 1.32% | 16 |
|
|
2022
Q3 | $6.96M | Buy |
27,626
+742
| +3% | +$180K | 1.45% | 14 |
|
|
2022
Q2 | $6.65M | Buy |
26,884
+122
| +0.5% | +$29.9K | 1.4% | 15 |
|
|
2022
Q1 | $6.47M | Buy |
26,762
+367
| +1% | +$84.3K | 1.24% | 18 |
|
|
2021
Q4 | $5.94M | Sell |
26,395
-496
| -2% | -$105K | 1.1% | 16 |
|
|
2021
Q3 | $5.72M | Sell |
26,891
-342
| -1% | -$78.7K | 1.03% | 20 |
|
|
2021
Q2 | $6.64M | Sell |
27,233
-172
| -0.6% | -$42.3K | 1.21% | 16 |
|
|
2021
Q1 | $6.82M | Sell |
27,405
-569
| -2% | -$136K | 1.33% | 13 |
|
|
2020
Q4 | $6.43M | Sell |
27,974
-1,032
| -4% | -$238K | 1.35% | 13 |
|
|
2020
Q3 | $7.37M | Sell |
29,006
-1,109
| -4% | -$275K | 1.69% | 11 |
|
|
2020
Q2 | $7.1M | Sell |
30,115
-1,348
| -4% | -$308K | 1.64% | 13 |
|
|
2020
Q1 | $6.38M | Sell |
31,463
-1,660
| -5% | -$363K | 1.76% | 15 |
|
|
2019
Q4 | $7.99M | Buy |
33,123
+515
| +2% | +$114K | 2% | 9 |
|
|
2019
Q3 | $6.31M | Buy |
32,608
+3,091
| +10% | +$593K | 1.73% | 10 |
|
|
2019
Q2 | $5.44M | Buy |
29,517
+2,399
| +9% | +$430K | 1.5% | 13 |
|
|
2019
Q1 | $5.15M | Buy |
27,118
+530
| +2% | +$101K | 1.48% | 12 |
|
|
2018
Q4 | $5.18M | Buy |
26,588
+941
| +4% | +$184K | 1.68% | 10 |
|
|
2018
Q3 | $5.32M | Buy |
25,647
+1,167
| +5% | +$230K | 1.84% | 9 |
|
|
2018
Q2 | $4.52M | Buy |
24,480
+1,414
| +6% | +$250K | 1.72% | 11 |
|
|
2018
Q1 | $3.93M | Buy |
23,066
+4,241
| +23% | +$779K | 1.46% | 12 |
|
|
2017
Q4 | $3.27M | Buy |
18,825
+5,627
| +43% | +$996K | 1.14% | 19 |
|
|
2017
Q3 | $2.46M | Buy |
13,198
+3,876
| +42% | +$687K | 0.84% | 21 |
|
|
2017
Q2 | $1.61M | Buy |
9,322
+8,328
| +838% | +$1.35M | 0.58% | 35 |
|
|
2017
Q1 | $163K | Buy |
994
+277
| +39% | +$46K | 0.06% | 152 |
|
|
2016
Q4 | $105K | Buy |
717
+2
| +0.3% | +$301 | 0.05% | 183 |
|
|
2016
Q3 | $119K | Buy |
715
+1
| +0.1% | +$169 | 0.06% | 163 |
|
|
2016
Q2 | $109K | Buy |
714
+33
| +5% | +$5.13K | 0.06% | 178 |
|
|
2016
Q1 | $102K | Buy |
681
+2
| +0.3% | +$297 | 0.05% | 181 |
|
|
2015
Q4 | $110K | Buy |
679
+11
| +2% | +$1.73K | 0.06% | 170 |
|
|
2015
Q3 | $92K | Buy |
668
+1
| +0.1% | +$158 | 0.06% | 183 |
|
|
2015
Q2 | $102K | Buy |
667
+1
| +0.2% | +$160 | 0.06% | 187 |
|
|
2015
Q1 | $106K | Buy |
666
+116
| +21% | +$18.3K | 0.06% | 165 |
|
|
2014
Q4 | $63K | Buy |
+550
| New | +$85.7K | 0.05% | 151 |
|
Other funds holding AMGN
VCM
VPM
Valley National Advisers's AMGN Position: Q1 2026 in Review
Valley National Advisers reduced its Amgen (AMGN) stake by 0.21% in Q1 2026, selling an estimated $8.2K and leaving 10,758 shares worth $3.79M. The position accounts for 0.49% of the portfolio, ranked #39.
Valley National Advisers first reported a position in AMGN in Q4 2014 and has held it in 46 quarters since. The position peaked at $7.99M in Q4 2019. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Valley National Advisers held 10,758 shares of Amgen worth $3.79M as of Q1 2026.
- Valley National Advisers sold 23 Amgen shares in Q1 2026, an estimated $8.2K.
- Amgen made up 0.49% of Valley National Advisers's portfolio in Q1 2026, its #39 holding.
- Valley National Advisers first reported a position in Amgen in Q4 2014 and has held it in 46 quarters since.
- Valley National Advisers's Amgen position peaked at $7.99M in Q4 2019.
- 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Valley National Advisers's 13F filing for Q1 2026, filed 15 Apr 2026.